AKT1 and Alzheimer disease: Hydrogen bonding analysis showed interactions between Akt1 and baicalein (THR-211, SER-205) (Figure 2B), kaempferol (THR-211, LYS-268) (Figure 2C), and quercetin (THR-211, LYS-268, ILE-290) (Figure 2D), supporting their potential as AD-target modulators.